IPO registrations (S-1, F-1) · Registrants

Schrodinger, Inc.

SEC CIK
1490978 · filings on EDGAR ↗
Registration
Form S-1, first filed 2020-01-10, last 2020-08-10; 2 initial registrations, 1 amendment
Outcome
Final prospectus filed 2020-02-06; declared effective 2020-02-05
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1540 BROADWAY, 24TH FLOOR, New York, NY 10036
EIN
95-4284541
Ticker
SDGR (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Schrodinger, Inc. on the corporate pages

Offering terms

Proposed price range
$14.00–$16.00 per share (S-1/A filed 2020-01-27)
Final price
$17.00 per share, above the range (424B4 filed 2020-02-06, an initial public offering)
Shares sold
11,882,352
Gross proceeds
$201,999,984 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol SDGR
Lead underwriters
Morgan Stanley (4,455,882 shares); BofA Securities (3,564,706 shares); Jefferies (2,732,941 shares); BMO Capital Markets (1,128,823 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 9

FiledFormWhat it isName as filedEDGAR
2020-01-10S-1S-1 (registration)Schrodinger, Inc.0001193125-20-005504 ↗
2020-01-27S-1/AS-1/A (amendment)Schrodinger, Inc.0001193125-20-014624 ↗
2020-02-05S-1MEFS-1MEF (added securities)Schrodinger, Inc.0001193125-20-025572 ↗
2020-02-05EFFECTEFFECT (declared effective)Schrodinger, Inc.9999999995-20-000259 ↗
2020-02-06424B4424B4 (final prospectus)Schrodinger, Inc.0001193125-20-026787 ↗
2020-08-10S-1S-1 (registration)Schrodinger, Inc.0001193125-20-214928 ↗
2020-08-12S-1MEFS-1MEF (added securities)Schrodinger, Inc.0001193125-20-217989 ↗
2020-08-12EFFECTEFFECT (declared effective)Schrodinger, Inc.9999999995-20-002125 ↗
2020-08-13424B4424B4 (final prospectus)Schrodinger, Inc.0001193125-20-219152 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2020-01-27S-1/Aregistration statement$14.00–$16.0010,000,000-Nasdaq SDGR4primary document; range, shares headline, cover names 4document ↗
2020-02-06424B4final prospectus$17.0011,882,352$201,999,984Nasdaq SDGR4primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Abel Robert LorneOfficerEVP, Science; See Remarks202020–2026
Akinsanya KarenOfficerPresident of R&D, Therapeutics; See Remarks182020–2026
BILL & MELINDA GATES FOUNDATION TRUSTTenPercentOwner42020
Brauner ShaneOfficerEVP & CIO; See Remarks72020–2021
Daniel JenniferOfficerEVP & Chief HR Officer; See Remarks; SVP & Chief HR Officer142020–2021
D'Cruz ConyOfficerEVP & Chief Business Officer; See Remarks162020–2021
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)TenPercentOwnerOther22020
Deerfield Mgmt IV, L.P.TenPercentOwnerOther22020
Deerfield Private Design Fund IV, L.P.TenPercentOwnerOther22020
Farid RamyDirector,Officer; Director,Officer,TenPercentOwnerPresident & CEO; See Remarks132020–2026
Flynn James ETenPercentOwnerOther22020person page Fuzzy
Friesner RichardDirector; Director,TenPercentOwner142020–2026
Herman JennyOfficerCAO; SVP & Controller; Vice President, Controller192020–2026
Kapeller-Libermann RosanaDirector92020–2026
Lebowitz JoelOfficerEVP & CFO; See Remarks162020–2021
Lorton Kenneth PatrickOfficerEVP & Chief Technology Officer; EVP, CTO & COO, Software; See Remarks232020–2026
Lynton MichaelDirector112020–2026
RF 2018 GRATTenPercentOwner12020
Schrodinger Equity Holdings, LLCTenPercentOwner382020–2021
Sender GaryDirector92020–2026
SHAW DAVID ETenPercentOwner412020–2021
Thornberry NancyDirector102020–2026
Tran YvonneOfficerEVP & Chief Legal Officer; EVP, CLO & CPO; See Remarks202020–2026
Weiser JorgOfficerEVP & Managing Director; See Remarks42020–2021
WRIGHT TIMOTHY MICHAELDirector22020
Deerfield Mgmt L.P.TenPercentOwnerOther12020
DEERFIELD PARTNERS, L.P.TenPercentOwnerOther12020
Chodakewitz JeffreyDirector82020–2026
GINSBERG GARY LDirector82020–2026
Ardai CharlesTenPercentOwner22021
OBEROI ARUNDirector62022–2026
Porges Geoffrey CraigOfficerEVP & CFO52022–2025
Dugan MargaretOfficerChief Medical Officer62023–2025
van Kralingen Bridget ADirector42025–2026
Jain RachitOfficerEVP & CFO62025–2026
Aklian Mannix VartanOfficerSee Remarks32025–2026
Abrams Therese MarieOfficerVP, Corporate Controller12026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2018-11-14Schrodinger, Inc.Biotechnology$115,000,000$107,824,987132
2015-06-19Schrodinger, Inc.Biotechnology$22,000,000$22,000,00021

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationSchrodinger, Inc.NYState business registriesname and state
Business registrationSchrodinger, Inc.NYState business registriesname and state
Business registrationSCHRODINGER, INC.NYState business registriesname and state
Business registrationSCHRODINGER, INC.NYState business registriesname and state
Business registrationSCHRODINGER, INC.NYState business registriesname and state
Business registrationSCHRODINGER, INC.NYState business registriesname and state
Business registrationSCHRODINGER, INC.NYState business registriesname and state
Business registrationSchrodinger, L.L.C.NYState business registriesname and state
Business registrationSCHRODINGER, L.L.C.NYState business registriesname and state
Plan sponsorSCHRODINGER, INC.ORForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientSCHRODINGER, INC.NYFederal spending (USAspending)name and state
Federal award recipientSCHRODINGER LLCNYFederal spending (USAspending)name and state
Form D issuerSchrodinger, Inc.NYForm D private offeringsCIK (EXACT)
SEC filerSchrodinger, Inc.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorSCHRODINGER, INC.EIN (EXACT)
Person pageJames E FlynnPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NY first:

More with this interest.

In other datasets, the same topic (Health) in NY:

Interests: Pharmaceutical Preparations · Health